Diabetologia

, Volume 37, Issue 7, pp 725–728 | Cite as

Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro

  • C. B. Verchere
  • D. A. D'Alessio
  • R. D. Palmiter
  • S. E. Kahn
Rapid Communications

Summary

To determine whether chronic overproduction of islet amyloid polypeptide alters beta-cell function, we studied a line of transgenic mice which overexpress islet amyloid polypeptide in their beta-cells. At 3 months of age, these transgenic mice had greater pancreatic content of both islet amyloid polypeptide and insulin. Further, basal and glucose-stimulated secretion of both islet amyloid polypeptide and insulin were also elevated in the perfused pancreas of the transgenic animals. These findings demonstrate that chronic overproduction and secretion of islet amyloid polypeptide are associated with increased insulin storage and enhanced secretion of insulin in vitro. This increase in insulin storage and secretion may be due to a direct effect of islet amyloid polypeptide on the beta-cell or a betacell adaptation to islet amyloid polypeptide-induced insulin resistance.

Key words

Insulin islet amyloid polypeptide pancreas secretion 

Abbreviations

IAPP

Islet amyloid polypeptide

bp

base pair

TFA

trifluoroacetic acid

IRI

immunoreactive insulin

SLI

somatostatin-like immunoreactivity

IAPP-LI

IAPP-like immunoreactivity

References

  1. 1.
    Cooper GJS, Day AJ, Willis AC, Roberts AN, Reid KBM, Leighton B (1989) Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus. Biochem Biophys Acta 1014: 247–258Google Scholar
  2. 2.
    Westermark P, Johnson KH, O'Brien TD, Betsholtz C (1992) Islet amyloid polypeptide — a novel controversy in diabetes research. Diabetologia 35: 297–303Google Scholar
  3. 3.
    Verchere CB, Kwok YN, Brown JC (1993) Inhibitory actions of a somatostatin analog, SMS 201–995, on pancreatic and gastric endocrine secretion. Pharmacology 46: 54–60Google Scholar
  4. 4.
    Kahn SE, Fujimoto WY, D'Alessio DA, Ensinck JW, Porte D Jr (1991) Glucose stimulates and potentiates islet amyloid polypeptide secretion by the B-cell. Horm Metab Res 23: 577–580Google Scholar
  5. 5.
    Ensinck JW, Laschansky EC, Vogel RE, Simonowitz DA, Roos BA, Francis BH (1989) Circulating prosomatostatinderived peptides. Differential responses to food ingestion. J Clin Invest 83: 1580–1589Google Scholar
  6. 6.
    Kuffert A, Stern JS, Curry DL (1988) Pancreatic hypersensitivity to glucose by young obese Zucker rats (fa/fa). Metabolism 37: 952–957Google Scholar
  7. 7.
    Kahn SE, Prigeon RL, McCulloch DK et al. (1993) Quantification of the relationship between insulin sensitivity and β- cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663–1672Google Scholar
  8. 8.
    Nagamatsu S, Carroll RJ, Grodsky GM, Steiner DF (1990) Lack of islet amyloid polypeptide regulation of insulin biosynthesis or secretion in normal rat islets. Diabetes 39: 871–874Google Scholar
  9. 9.
    Haegerstrand A, Dalsgaard CJ, Jonzon B, Larsson O, Nilsson J (1990) Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci 87: 3299–3303Google Scholar
  10. 10.
    Kahn SE, Verchere CB, D'Alessio DA, Cook DL, Fujimoto WY (1993) Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway. Diabetologia 36: 570–573Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • C. B. Verchere
    • 1
    • 2
  • D. A. D'Alessio
    • 1
  • R. D. Palmiter
    • 3
  • S. E. Kahn
    • 1
    • 2
  1. 1.Division of Metabolism, Endocrinology and Nutrition, Department of MedicineUniversity of WashingtonSeattleUSA
  2. 2.Veterans Affairs Medical CenterSeattleUSA
  3. 3.Howard Hughes Medical InstituteUniversity of WashingtonSeattleUSA

Personalised recommendations